World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia - a short version for primary care

International Journal of Psychiatry in Clinical Practice
Alkomiet HasanWFSBP Task Force on Treatment Guidelines for Schizophrenia

Abstract

Schizophrenia is a severe mental disorder and many patients are treated in primary care settings. Apart from the pharmacological management of disease-associated symptoms, the detection and treatment of side effects is of the utmost importance in clinical practice. The purpose of this publication is to offer relevant evidence-based recommendations for the biological treatment of schizophrenia in primary care. This publication is a short and practice-oriented summary of Parts I-III of the World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia. The recommendations were developed by the authors and consented by a task force of international experts. Guideline recommendations are based on randomized-controlled trials and supplemented with non-randomized trials and meta-analyses where necessary. Antipsychotics of different chemical classes are the first-line pharmacological treatments for schizophrenia. Specific circumstances (e.g., suicidality, depression, substance dependence) may need additional treatment options. The pharmacological and non-pharmacological management of side effects is of crucial importance for the long-term treatment in all settings of the healthcare ...Continue Reading

References

Jul 1, 1990·Schizophrenia Research·D AddingtonB Schissel
Jan 1, 1985·Schizophrenia Bulletin·W T CarpenterL D Alphs
Mar 9, 2004·The Journal of Clinical Psychiatry·UNKNOWN American Diabetes AssociationUNKNOWN North American Association for the Study of Obesity
May 27, 2005·PLoS Medicine·Sukanta SahaJohn McGrath
Oct 14, 2005·Schizophrenia Bulletin·Philip D HarveyChristopher R Bowie
Feb 17, 2006·Schizophrenia Bulletin·Brian KirkpatrickStephen R Marder
Oct 9, 2007·Acta Psychiatrica Scandinavica·S LeuchtN Sartorius
Dec 4, 2009·Schizophrenia Bulletin·Robert W BuchananUNKNOWN Schizophrenia Patient Outcomes Research Team (PORT)
Mar 8, 2011·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Marc DE HertStefan Leucht
Jun 3, 2011·World Psychiatry : Official Journal of the World Psychiatric Association (WPA)·Marc De HertChristoph U Correll
May 1, 2012·International Journal of Psychiatry in Clinical Practice·Borwin BandelowUNKNOWN WFSBP Task Force on Anxiety Disorders, OCD and PTSD
Jul 28, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN World Federation of Societies of Biological Psychiatry (WFSBP) Task Force on Treatment Guidelines for Schizophrenia
Dec 12, 2012·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN WFSBP Task force on Treatment Guidelines for Schizophrenia
Aug 27, 2014·The American Journal of Psychiatry·Georgios PetridesAlan Mendelowitz
Mar 31, 2015·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Alkomiet HasanUNKNOWN WFSBP Task Force on Treatment Guidelines for Schizophrenia
Jun 6, 2015·The American Journal of Psychiatry·Myrto T SamaraStefan Leucht
Sep 6, 2015·Current Psychiatry Reports·Rose JonesChristopher Fear
Oct 29, 2015·JAMA Psychiatry·Mark OlfsonT Scott Stroup

❮ Previous
Next ❯

Citations

May 18, 2019·The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry·Siegfried Kasper
Jul 3, 2019·The International Journal of Neuropsychopharmacology·Sermin TotoAlexandra Neyazi
Aug 30, 2019·Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova·I N Dyakov, S K Zyryanov
Nov 20, 2019·Psychological Medicine·Nicola WarrenDan Siskind
Jun 4, 2020·Revista brasileira de enfermagem·Elen Cristiane Doná OliveiraSilvia Justina Papini
May 26, 2018·Open Biology·Shani SternFred H Gage
Oct 21, 2020·European Journal of Clinical Pharmacology·Olorunfemi A OshagbemiIsmaeel Yunusa
Dec 1, 2020·Australian Health Review : a Publication of the Australian Hospital Association·Nadia FriendDan Siskind
Jan 12, 2021·Thérapie·Louise CartonRomain Guilhaumou
Nov 18, 2020·Clinical Medicine : Journal of the Royal College of Physicians of London·Winifred EkezieJo Leonardi-Bee
Jul 1, 2020·L'Encéphale·B de ToffolC Hingray
May 7, 2021·The Journal of Neuropsychiatry and Clinical Neurosciences·Catalina CosteiRoberta La Piana
May 14, 2021·Movement Disorders Clinical Practice·Pedro J Garcia Ruiz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Related Papers

The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
Michael SoykaWFSBP Task Force on Treatment, Guidelines for Substance Use Disorders
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
Peter FalkaiWFSBP Task Force on Treatment Guidelines for Schizophrenia
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
Alkomiet HasanWFSBP Task Force on Treatment Guidelines for Schizophrenia
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry
Florence ThibautWFSBP Task Force on Sexual Disorders
© 2022 Meta ULC. All rights reserved